India is closely monitoring the potential impact of the US’s proposed tariffs of up to 100% on imported branded and patented pharmaceutical drugs, set to begin October 1. The relevant ministries are examining the matter, recognizing the US as India’s largest pharma export market, accounting for approximately $10 billion in FY25.
West Bengal Chief Minister Mamata Banerjee spearheaded a massive protest rally in Jhargram, condemning alleged attacks on Bengali-speaking migrants and accusing the BJP of orchestrating […]
India’s wicketkeeper-batter Dhruv Jurel won a cash prize of $300 for his exceptional performance in a fielding drill. The drill, designed to sharpen fielding skills […]
Elon Musk concludes his tenure as a Special Government Employee leading the Department of Government Efficiency under the Trump 2.0 Administration. He thanks President Trump […]